Intas Pharma appoints Akash Kalal as General Manager - API Production

Written By :  Ruchika Sharma
Published On 2025-09-29 10:44 GMT   |   Update On 2025-09-29 10:50 GMT
Advertisement

Ahmedabad: Intas Pharma has announced the appointment of Akash Kalal as General Manager – API Production.

The company shared the update in a recent LinkedIn post, highlighting Kalal’s extensive experience in pharmaceutical production and operations management.

"With extensive experience in pharmaceutical production and operations management, Akash brings strong expertise in production planning, process optimization, manpower management, and cross-functional collaboration," Intas stated.
Advertisement
"I am excited to contribute my experience and passion for operational excellence to drive efficiency, innovation, and growth in API production at Intas Pharmaceuticals," Akash Kalal said.

Prior to joining Intas, Kalal served as Site Operation Head at SPC Lifesciences. Over the course of his career, he has held key roles at several major pharmaceutical companies, including Macleods Pharmaceuticals, Lupin, Ranbaxy, Symbiotec Pharma, and Dishman Pharmaceutical & Chemicals Ltd.

Intas is a vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. Intas has set up a network of subsidiaries, under the umbrella name of Accord Healthcare to operate in global markets. Over the years, Intas has grown both organically and via acquisition, expanding its product portfolio and operations year on year. It is currently present in more than 85 countries worldwide. Intas is currently investing in a higher barrier to entry developments such as Biosimilar and New Chemical Entities.

Read also: Intas Pharma appoints Dr Ajay Kumar Handa as new Executive Vice President - RnD

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News